We have demonstrated in this study that long-term, interleukin-2 (IL-2)-dependent, salmonella antigenspecific T-lymphocyte lines, as well as peritoneal exudate-enriched T cells, could be developed from both the antigen-sensitized inguinal and periaortic lymph nodes. Only those lines (salmonella-specific lymph node cells or peritoneal exudate T cells) were capable of adoptively transferring significant host protection (P < 0.01) compared with the immune reactions of lethally challenged naive controls or of mice that had ovalbuminspecific T-cell lines transferred. Of particular interest was the finding that IL-2-dependent T-cell lines derived from the lymph nodes could only confer host protection to naive mice when both the transfer and challenge dose were administered via the intravenous route. Likewise, those T-cell lines derived from the peritoneal exudate were only capable of adoptively transferring significant protection when the cells and challenge dose of salmonellae were administered intraperitoneally. These studies indicate that systemic host protection can be transferred to naive mice, but depending on the source, the IL-2-dependent T-cell lines (lymph node or peritoneally isolated) functioned differentially upon challenge. Also, the results of this study indicate that the administration of greater numbers of IL-2-specific T cells may result in decreased, rather than enhanced, host protection. This may be due to the fact that the IL-2-dependent T-cell population consisted of 20 to 25% Lyt-2,3+ cells, indicating that cells of the suppressor/cytotoxic phenotype were present. Thus, increasing the number of cells transferred may result in an abrogation of protection.
T lymphocytes are central in immune reactions, such as cellular cytotoxicity, delayed hypersensitivity, graft-versushost reactivity, antibody production, immune tolerance, and allotypic suppression. The ability to expand antigen-specific T lymphocytes has allowed more opportunity for in vitro and in vivo studies of various immune functions. It has been demonstrated that T lymphocytes can proliferate and functionally differentiate in an antigen-specific fashion (23) . The use of such expanded T cells in adoptive transfer studies has not always provided evidence of effective or appropriate in situ activities without certain modifications of the experimental design (e.g., change in numbers or route of administration of the transferred cells) (12, 14) .
This laboratory has isolated and partially characterized Salmonella antigen-specific T-cell lines (20) . In attempts to test the relevance of demonstrated in vitro activities to in vivo function, adoptive transfer studies were performed. Such studies have been useful in investigating the role(s) of T-cell lines directed against other facultative intracellular parasites (12) . With the advent of techniques permitting the in vitro enrichment of antigen-specific T cells and subsequent adoptive immunotherapy studies, new areas of investigation have been opened. The observed lack of correlation between in vitro abilities and in vivo activity has been ascribed to aberrant migratory patterns (1, 3, 7, 8, 18) . Kaufmann (11) reported that high numbers of adoptively transferred T-cell clones were required for systemic delayedtype hypersensitivity transfer, while lower numbers were capable of local subcutaneous antibacterial protection against the facultative intracellular parasite Listeria monocytogenes. It was suggested that the failure of the T-cell clones to confer significant protection was because the in vitro-maintained cells had an altered migration pattern. Such phenomena have been reported by others as well (1, 7, 8, 16 Antigens. Spent medium antigen (SMA) was prepared from S. typhimurium RIA (vaccine strain) according to Cohn (4) , and as modified by Collins and Mackaness (5) and Plant and Glynn (21) . The SMA was divided into aliquots and stored at -20°C until needed. Ovalbumin (OVA; Sigma Chemical Co., St. Louis, Mo.) was used to prepare and maintain OVA antigen-specific lymph node T-cell lines.
Generation of SMA-specific LNCs. Antigen-specific T lymphocytes from the lymph nodes were prepared essentially according to Corradin et al. (6) , with some modifications as described by Kaufmann et al. (14) . Briefly, the mice were injected subcutaneously at the base of the tail with 25 ,ug of SMA emulsified in complete Freund adjuvant. After 7 days, the periaortic and inguinal lymph nodes were aseptically removed and a single-cell suspension was prepared in RPMI 1640 with 25 mM HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid) (MA Bioproducts, Walkersville, Md.), supplemented with 5% fetal bovine serum (Hyclone Laboratories, Logan, Utah). The lymph node cell (LNC) suspension was placed in a 15-ml conical centrifuge tube (Corning Glass Works, Corning, N.Y.) and placed on ice for 20 min. The cell suspensions were then centrifuged at 250 x g for 10 min. The cell pellet was suspended in complete T-cell medium (CTCM): RPMI 1640 with 25 mM HEPES, 10% fetal bovine serum, 5 x 10-5 M 2-mercaptoethanol, 2 mM L-glutamine (MA Bioproducts), and 50 ,ug of gentamicin per ml. The cells were counted and adjusted to a concentration of 2 x 105/ml. Aliquots of 1 ml of the cell suspension were plated in wells of a 24-well plate (Costar, Cambridge, Mass.) in the presence of 50 ,ug of SMA for 4 days at 37°C in a 5% CO2 incubator. At the conclusion of this incubation period, the contents of the wells were aspirated and layered onto Histopaque (density, 1.077; Sigma). This cell gradient was centrifuged at 300 x g for 15 min. The cells at the interface were aspirated and washed in RPMI 1640, supplemented with 5% fetal bovine serum. The cell pellet was suspended at 2 x 105/ml in CTCM. The in vitro antigenexpanded cells were cultured with interleukin-2 (IL-2; Genzyme Corporation, Boston, Mass.) at 10 U/105 cells for 4 days at 37°C in 5% CO2. At the conclusion of this period, the viable blastlike cells were again enriched by layering onto Histopaque and harvesting the cells at the interface. These antigen-reactive cells were then cultured in the presence of antigen at 40 ,ug of SMA per 2 x 105 antigen-reactive cells and 6 x 105 irradiated syngeneic splenic feeder cells. The cycle of antigen and feeder cells was repeated once every 7 days, with exogenous IL-2 supplied every 14 days.
Generation of OVA antigen-specific T-cell lines. As a control for the adoptive transfer studies, OVA antigen-specific, continuous, IL-2-dependent T lines were produced and maintained. All procedures involved in the isolation of the stimulated LNCs, culturing, and addition of feeder cells and IL-2 were identical to those used for the generation of SMA T-cell lines, with the following exceptions: the mice were injected with a 50-,ug dose of OVA to sensitize the T cells and 50 jig of OVA was used as the concentration of antigen to maintain the T cells in vitro.
Immunization and isolation of PETLEs. The method of Schwartz et al. (22) 
RESULTS AND DISCUSSION
The results of the adoptive transfer studies using lymph node-derived T cells are reported in Table 1 . The nonvaccinated naive controls demonstrated marked susceptibility to the pathogen, S. typhimurium. All of the control animals were dead by 7.6 days postchallenge in the group receiving 10 50% lethal doses (LD50s) or by 7.3 days in the group receiving 20 LD50s. However, 10% of the OVA T-celltransferred mice did survive the challenge infection. Possibly these cells were producing lymphokines, such as IL-2 or gamma interferon, which allowed for some transient activation of the immune system. The RIA SMA-maintained T-cell lines were able to confer a significant survival advantage (P < 0.01 compared with the controls using the chi-square analysis), with 68% of the mice surviving the 10 LD50s of salmonellae and 50% surviving the 20 LD50 challenge doses. Thus, the in vitro-maintained pool of T cells retained their capacity to respond to the RIA SMA and function in vivo in a host-protective manner. These T cells were not modified to such an extent through the in vitro culturing as to prevent a functional immune response from occurring. Such cell line characteristics have been observed in the murine listeriosis system (11, 13, 15) , as well as in the murine tuberculosis model (17) .
When the number of T cells transferred to the naive recipient mice was increased from 1 x 106 to 5 x 106 cells, there was a loss in protective capacity following the i.v. transfer. After performing the phenotyping of the continuous T-cell lines (LNCs or PETLEs), we found that 75 to 80% of the cells were Lyt-1+, 10 to 12% were Lyt-2,3+, and 2 to 5%
were Lyt-1,2,3+. Possibly this decreased protection resulting from the injection of 5 x 106 T cells was due to suppressor-T-cell activity, since this phenotype was present in all of our continuous T-cell lines and the mice received five times the number of potential suppressor/cytotoxic cells in this experiment. In Table 2 , the results of adoptive transfer studies using PETLEs are presented. It was also shown in this study that the naive controls were highly susceptible to lethal challenge with the SR-11 strain, with no survivors 30 days postchallenge and a mean survival time of 12.4 days. The survival data presented demonstrate that the immunization protocol used to generate RIA antigen-specific T cells is capable of Table 2) . The difference in observed effectiveness of function of the transferred cells must therefore be due to some quality of the T lymphocytes themselves. In order to see if the lymphocytes derived from lymph nodes displayed similar variability in protective capability, further adoptive transfer studies were performed. The results of such experiments are presented in Table 3 . It is evident that a similar phenomenon occurred when the lymph node-derived T cells were transferred i.p. or i.v., with no significant protection conferred when the i.p. route was used. Perhaps an explanation lies in the fact that the lymph node-and peritoneal exudate-derived T cells require some, as yet unexplained, homing communication interaction in the spleen (upon i.v. transfer or challenge) or the peritoneum (upon i.p. transfer or challenge). As has already been suggested, aberrant migration patterns may result from inappro- (1, 7, 8) .
The results presented herein demonstrate both the potential benefits and difficulties associated with the utilization of the technique of adoptive immunotherapy with antigenspecific T cells. One approach at overcoming the observed lack of effectiveness has been to administer exogenous IL-2 at the time of transfer of the in vitro-expanded T cells (2) . Such an approach does not explain the reasons for observed lack of efficacy of adoptively transferred cells but attempts to further expand the cells in vivo in hopes of improving the chance that enough cells will reach the appropriate sites.
